摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[2-[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-bromo-6-[(5-chloropyridin-2-yl)carbamoyl]phenyl]-1-propan-2-ylpiperidine-4-carboxamide

中文名称
——
中文别名
——
英文名称
N-[2-[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-bromo-6-[(5-chloropyridin-2-yl)carbamoyl]phenyl]-1-propan-2-ylpiperidine-4-carboxamide
英文别名
——
N-[2-[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-bromo-6-[(5-chloropyridin-2-yl)carbamoyl]phenyl]-1-propan-2-ylpiperidine-4-carboxamide化学式
CAS
——
化学式
C29H37BrClN5O8
mdl
——
分子量
699.0
InChiKey
DDLWZDOOPRZDPA-GCVKPHKGSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    44
  • 可旋转键数:
    9
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.52
  • 拓扑面积:
    183
  • 氢给体数:
    6
  • 氢受体数:
    10

文献信息

  • Substituted benzene derivatives or salts thereof
    申请人:——
    公开号:US20040077555A1
    公开(公告)日:2004-04-22
    There are provided compounds having an anticoagulant action on the basis of inhibition of activated blood coagulation factor X and being useful as anticoagulants or preventive/therapeutic agents for diseases induced by thrombosis or embolism. Effective ingredients are the compounds such as 4′-bromo-2′-[(5-chloro-2-pyridyl)carbamoyl]-6′-&bgr;-D-galactopyranosyloxy-1-isopropylpiperidine-4-carboxanilide, 2′-(2-acetamido-2-deoxy-&bgr;-D-glucopyranosyloxy)-4′-bromo-6′-[(5-chloro-2-pyridyl)carbamoyl]-1-isopropylpiperidine-4-carboxanilide, etc. or salts thereof.
    提供了一些化合物,基于抑制激活的血液凝血因子X而具有抗凝作用,并可用作抗凝剂或预防/治疗由血栓形成或栓塞引起的疾病的药物。有效成分包括化合物,如4'-溴-2'-[(5-氯-2-吡啶基)氨基甲酰]-6'-β-D-半乳糖苷氧基-1-异丙基哌啶-4-羧酰胺,2'-(2-乙酰氨基-2-脱氧-β-D-葡萄糖苷氧基)-4'-溴-6'-[(5-氯-2-吡啶基)氨基甲酰]-1-异丙基哌啶-4-羧酰胺等,或其盐。
  • SUBSTITUTED BENZENE DERIVATIVES OR SALTS THEREOF
    申请人:Ishihara Tsukasa
    公开号:US20090137498A1
    公开(公告)日:2009-05-28
    There are provided compounds having an anticoagulant action on the basis of inhibition of activated blood coagulation factor X and being useful as anticoagulants or preventive/therapeutic agents for diseases induced by thrombosis or embolism. Effective ingredients are the compounds such as 4′-bromo-2′-[(5-chloro-2-pyridyl)carbamoyl]-6′-β-D-galactopyranosyloxy-1-isopropylpiperidine-4-carboxanilide, 2′-(2-acetamido-2-deoxy-β-D-glucopyranosyloxy)-4′-bromo-6′-[(5-chloro-2-pyridyl)carbamoyl]-1-isopropylpiperidine-4-carboxanilide, etc. or salts thereof.
    提供了一些化合物,基于抑制活化的血液凝血因子X,具有抗凝作用,并可用作抗凝剂或预防/治疗由血栓形成或栓塞引起的疾病的药物。有效成分是化合物,例如4'-溴-2'-[(5-氯-2-吡啶基)氨基甲酰基]-6'-β-D-半乳糖苷氧基-1-异丙基哌啶-4-羧酰胺,2'-(2-乙酰氨基-2-脱氧-β-D-葡萄糖苷氧基)-4'-溴-6'-[(5-氯-2-吡啶基)氨基甲酰基]-1-异丙基哌啶-4-羧酰胺等或其盐。
  • SUBSTITUTED PHENOL DERIVATIVES OR SALTS THEREOF AS INHIBITORS OF COAGULATION FACTOR X
    申请人:Astellas Pharma Inc.
    公开号:EP1336605B1
    公开(公告)日:2006-04-12
  • EP1336605A4
    申请人:——
    公开号:EP1336605A4
    公开(公告)日:2004-01-28
  • US7504417B2
    申请人:——
    公开号:US7504417B2
    公开(公告)日:2009-03-17
查看更多